Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

The Trump White House on Friday replaced the covid.gov website that provided resources and information on COVID-19 with a ...

Conditions like autism or Asperger’s syndrome qualify if they meet Sars’s standard for "moderate to severe" limitation.

Get Instant Summarized Text (Gist) A new method, Deep Novel Mutation Search (DNMS), uses AI to predict potential mutations in the SARS-CoV-2 spike protein. By employing a fine-tuned language model ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2 ... plays a dual role in a wide range of medical applications owing to its neuroprotective ...

More than half of those who died were over the age of 65. There was a second, much smaller outbreak of SARS in 2004, linked to a medical lab in China. It probably occurred as a result of direct ...

But Harvard Medical School’s Haytham Kaafarani ... many symptoms that showed up.” Now, with SARS-CoV-2 having infected more than 100 million people and counting, it’s clear that the virus can indeed ...

SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...

Medical scheme tax credits are far too important for them to be used to fund NHI as it takes the load off public healthcare.